Changes in bone density and osteoblast function after completion of cyclical etidronate treatment
β Scribed by A. Fairney; K. Isaac; P. Kyd; M. Murphy; E. Thomas; J. Wilson
- Publisher
- Springer-Verlag
- Year
- 1996
- Tongue
- English
- Weight
- 130 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Androgen receptor blocking agents have become an established form of therapy for men with disseminated prostate carcinoma. The purpose of this study was to evaluate markers of bone turnover and to measure bone mineral densities (BMD) in men with disseminated prostate carcinoma treat
## Abstract ## Aims Expanded indications for neuromodulation are continually being explored. We evaluated secondary changes in bowel function after successful neuromodulation for voiding symptoms. ## Methods Patients in our prospective neuromodulation database study with comorbid irritable bowel